Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1088655

Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer


Petrić Miše, Branka; Lisica Šikić, Nataša; Tomić, Snježana; Juretić, Antonio; Spagnoli , Giulio; Čapkun, Vesna; Vrdoljak, Eduard
Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer // ESGO
Beč, Austrija, 2017. str. 45-46 (poster, međunarodna recenzija, sažetak, ostalo)


CROSBI ID: 1088655 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer

Autori
Petrić Miše, Branka ; Lisica Šikić, Nataša ; Tomić, Snježana ; Juretić, Antonio ; Spagnoli , Giulio ; Čapkun, Vesna ; Vrdoljak, Eduard

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Skup
ESGO

Mjesto i datum
Beč, Austrija, 04.-07.11.2017

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
MAGE-A10, Platinum sensitivity, Serous ovarian cancer
(MAGE-A10, platinum sensitivity, serous ovarian cancer)

Sažetak
Correlation between MAGE-A10 expression and platinum sensitivity in ovarian cancer patients

Izvorni jezik
Engleski



POVEZANOST RADA



Citiraj ovu publikaciju:

Petrić Miše, Branka; Lisica Šikić, Nataša; Tomić, Snježana; Juretić, Antonio; Spagnoli , Giulio; Čapkun, Vesna; Vrdoljak, Eduard
Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer // ESGO
Beč, Austrija, 2017. str. 45-46 (poster, međunarodna recenzija, sažetak, ostalo)
Petrić Miše, B., Lisica Šikić, N., Tomić, S., Juretić, A., Spagnoli , G., Čapkun, V. & Vrdoljak, E. (2017) Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer. U: ESGO.
@article{article, author = {Petri\'{c} Mi\v{s}e, Branka and Lisica \v{S}iki\'{c}, Nata\v{s}a and Tomi\'{c}, Snje\v{z}ana and Jureti\'{c}, Antonio and Spagnoli, Giulio and \v{C}apkun, Vesna and Vrdoljak, Eduard}, year = {2017}, pages = {45-46}, keywords = {MAGE-A10, Platinum sensitivity, Serous ovarian cancer}, title = {Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer}, keyword = {MAGE-A10, Platinum sensitivity, Serous ovarian cancer}, publisherplace = {Be\v{c}, Austrija} }
@article{article, author = {Petri\'{c} Mi\v{s}e, Branka and Lisica \v{S}iki\'{c}, Nata\v{s}a and Tomi\'{c}, Snje\v{z}ana and Jureti\'{c}, Antonio and Spagnoli, Giulio and \v{C}apkun, Vesna and Vrdoljak, Eduard}, year = {2017}, pages = {45-46}, keywords = {MAGE-A10, platinum sensitivity, serous ovarian cancer}, title = {Impact og MAGE-A10 immunoexpression on efficacy of the first -line platinum-based chemotherapy in advanced high-grade serous ovarian cancer}, keyword = {MAGE-A10, platinum sensitivity, serous ovarian cancer}, publisherplace = {Be\v{c}, Austrija} }




Contrast
Increase Font
Decrease Font
Dyslexic Font